220 mutation in the hemagglutinin of avian influenza A (H7N9) virus alters antigenicity during vaccine strain development

References

• Gao R, Cao B, Hu Y, Feng Z, Wang D, Hu W, Chen J, Jie Z, Qiu H, Xu K, et al. Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med. 2013;368(20):1888–97. doi:10.1056/NEJMoa1304459.
   PubMed Web of Science ®Google Scholar
• Kreijtz JH, Kroeze EJ, Stittelaar KJ, de Waal L, van Amerongen G, van Trierum S, van Run P, Bestebroer T, Kuiken T, Fouchier RA, et al. Low pathogenic avian influenza A(H7N9) virus causes high mortality in ferrets upon intratracheal challenge: A model to study intervention strategies. Vaccine. 2013;31(43):4995–9. doi:10.1016/j.vaccine.2013.06.071.
   PubMed Web of Science ®Google Scholar
• Wang D, Yang L, Zhu W, Zhang Y, Zou S, Bo H, Gao R, Dong J, Huang W, Guo J, et al. Two outbreak sources of influenza A (H7N9) viruses have been established in China. J Virol. 2016;90(12):5561–73. doi:10.1128/JVI.03173-15.
   PubMed Web of Science ®Google Scholar
• Ip DK, Liao Q, Wu P, Gao Z, Cao B, Feng L, Xu X, Jiang H, Li M, Bao J, et al. Detection of mild to moderate influenza A/H7N9 infection by China's national sentinel surveillance system for influenza-like illness: Case series. BMJ. 2013;346:f3693. doi:10.1136/bmj.f3693.
   PubMedGoogle Scholar
• Peiris JS, Cowling BJ, Wu JT, Feng L, Guan Y, Yu H, Leung GM. Interventions to reduce zoonotic and pandemic risks from avian influenza in Asia. Lancet Infect Dis. 2016;16(2):252–8. doi:10.1016/S1473-3099(15)00502-2.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Monthly risk assessment summary. [accessed 2017 Sep 2]. http://www.who.int/influenza/human_animal_interface/HAI_Risk_Assessment/en/.
   Google Scholar
• World Health Organization. Human infection with avian influenza A(H7N9) virus –China. Disease outbreak news. 27 February 2017. [accessed 2017 Sep 2]. http://www.who.int/csr/don/27-february-2017-ah7n9-china/en/.
   Google Scholar
• Zhou L, Tan Y, Kang M, Liu F, Ren R, Wang Y, Chen T, Yang Y, Li C, Wu J, et al. Preliminary epidemiology of human infections with highly pathogenic avian influenza A(H7N9) virus, China, 2017. Emerg Infect Dis. 2017;23:1355–9. https://doi.org/10.3201/eid2308.170640. doi:10.3201/eid2308.170640.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Monthly risk assessment summary; 30 Oct 2017. [accessed 2017 Nov 23]. http://www.who.int/influenza/human_animal_interface/Influenza_Summary_IRA_HA_interface_10_30_2017.pdf?ua=1.
   Google Scholar
• World Health Organization. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness. Wkly Epidemiol Rec. 2017; 24;92(12):129–44.
   PubMedGoogle Scholar
• De Groot AS, Ardito M, Terry F, Levitz L, Ross T, Moise L, Martin W. Low immunogenicity predicted for emerging avian-origin H7N9: Implication for influenza vaccine design. Hum Vaccin Immunother. 2013;9(5):950–6. doi:10.4161/hv.24939.
   PubMed Web of Science ®Google Scholar
• Li Q, Zhou L, Zhou M, Chen Z, Li F, Wu H, Xiang N, Chen E, Tang F, Wang D, et al. Epidemiology of the avian influenza a (h7n9) outbreak in china. N Engl J Med. 2013;370(6):520–32. doi:10.1056/NEJMoa1304617.
   PubMed Web of Science ®Google Scholar
• Kile JC, Ren R, Liu L, Greene CM, Roguski K, Iuliano AD, Jang Y, Jones J, ThorS, SongY, et al. Update: Increase in human infections with novel asian lineage avian influenza a(h7n9) viruses during the fifth epidemic — china, october 1, 2016–august 7, 2017. MMWR Morb Mortal Wkly Rep. 2017;66(35):928–932. doi:10.15585/mmwr.mm6635a2.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Update of WHO biosafety risk assessment andguidelines for the production and quality control of human influenza vaccines against avian influenza A (H7N9) virus; 10 May 2013. [accessed 2017 Sep 2]. http://www.who.int/biological/areas/vaccines/influenza/biosafetyrisk assessment_10may2013.pdf.
   Google Scholar
• World Health Organization. A description of the process of seasonal and h5n1 influenza vaccine virus selection and development; 19 Nov 2007. [accessed 2017 Sep 2]. http://apps.who.int/gb/pip/pdf_files/Fluvaccvirusselection.pdf?ua=1.
   Google Scholar
• Zhu W, Zhou J, Li Z, Yang L, Li X, Huang W, Zou S, Chen W, Wei H, Tang J, et al. Biological characterisation of the emerged highly pathogenic avian influenza (HPAI) A(H7N9) viruses in humans, in mainland China, 2016 to 2017. Euro Surveill. 2017;22(19):pii: 30533. doi:10.2807/1560-7917.ES.2017.22.19.30533.
   PubMedGoogle Scholar
• World Organization for Animal Health(OIE). Avian influenza (infection with avian influenza viruses). In: Manual of diagnostic tests and vaccines for terrestrial animals. Paris: OIE; 2016. p.1–23.
   Google Scholar
• Iuliano AD, Jang Y, Jones J, Davis CT, Wentworth DE, Uyeki TM, Roguski K, Thompson MG, Gubareva L, Fry AM, et al. Increase in human infections with avian influenza a(h7n9) virus during the fifth epidemic — china, October 2016–February 2017. MMWR Morb Mortal Wkly Rep. 2017;66(9):254–255. doi:10.15585/mmwr.mm6609e2.
   PubMed Web of Science ®Google Scholar
• Kageyama T, Fujisaki S, Takashita E, Xu H, YamadaS, Uchida Y, Neumann G, Saito T, Kawaoka Y, Tashiro M. Genetic analysis of novel avian A(H7N9) influenza viruses isolated from patients in China, February to April 2013. Euro Surveill. 2013; 11;18(15):20453.
   PubMedGoogle Scholar
• Dawood FS, Iuliano AD, Reed C, Meltzer MI, Shay DK, Cheng PY, Bandaranayake D, Breiman RF, Brooks WA, Buchy P, et al. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: A modelling study. Lancet Infect Dis. 2012;12(9):687–95. doi:10.1016/S1473-3099(12)70121-4.
   PubMed Web of Science ®Google Scholar
• Wang W, Lu J, Cotter CR, Wen K, Jin H, Chen Z. Identification of critical residues in the hemagglutinin and neuraminidase of influenza virus h1n1pdm for vaccine virus replication in embryonated chicken eggs. J Virol. 2013;87(8):4642–9. doi:10.1128/JVI.03271-12.
   PubMed Web of Science ®Google Scholar
• Nakamura K, Shirakura M, Suzuki Y, Naito T, Fujisaki S, Tashiro M, Nobusawa E. Development of a high–yield reassortant influenza vaccine virus derived from the A/Anhui /1/2013(H7N9) strain. Vaccine. 2016;34(3):328–33. doi:10.1016/j.vaccine.2015.11.050.
   PubMed Web of Science ®Google Scholar
• Barman S, Franks J, Turner JC, Yoon SW, Webster RG, Webby RJ. Egg-adaptive mutations in H3N2v vaccine virus enhance egg-based production without loss of antigenicity or immunogenicity. Vaccine. 2015;33(28):3186–92. doi:10.1016/j.vaccine.2015.05.011.
   PubMed Web of Science ®Google Scholar
• Ridenour C, Johnson A, Winne E, Hossain J, Mateu-Petit G, Balish A, Santana W, Kim T, Davis C, Cox NJ, et al. Development of influenza A(H7N9) candidate vaccine viruses with improved hemagglutinin antigen yield in eggs. Influenza and Other Respiratory Viruses. 2015;9(5):263–70. doi:10.1111/irv.12322.
   PubMed Web of Science ®Google Scholar
• Liu Q, Lu L, Sun Z, Chen GW, Wen Y, Jiang S. Genomic signature and protein sequence analysis of a novel influenza A (H7N9) virus that causes an outbreak in humans in China. Microbes Infect. 2013; 15(6–7):432–9. doi:10.1016/j.micinf.2013.04.004.
   PubMed Web of Science ®Google Scholar
• Wu Y, Bi Y, Vavricka CJ, Sun X, Zhang Y, Gao F, Zhao M, Xiao H, Qin C, He J, et al. Characterization of two distinct neuraminidases from avian-origin human-infecting H7N9 influenza viruses. Cell Res. 2013;23(12):1347–55. doi:10.1038/cr.2013.144.
   PubMed Web of Science ®Google Scholar
• Fulvini AA, Ramanunninair M, Le J, Pokorny BA, Arroyo JM, Silverman J, Devis R, Bucher D. Gene constellation of influenza a virus reassortants with high growth phenotype prepared as seed candidates for vaccine production. PLoS ONE. 2011;6(6):e20823. doi:10.1371/journal.pone.0020823.
   PubMed Web of Science ®Google Scholar
• Chen Z, Baz M, Lu J, Paskel M, Santos C, Subbarao K, Jin H, Matsuoka Y. Development of a high-yield live attenuated h7n9 influenza virus vaccine that provides protection against homologous and heterologous h7 wild-type viruses in ferrets. J Virol. 2014;88(12):7016–23. doi:10.1128/JVI.00100-14.
   PubMed Web of Science ®Google Scholar
• Zhang H, Liu M, Zeng X, Zhao X, Deng Z, Yang L, Chen W, Li Z, Jiao M, Xia W, et al. Identification of a novel reassortant A (H9N6) virus in live poultry markets in Poyang Lake region, China. Arch Virol. 2017;162(12):3681–3690. doi:10.1007/s00705-017-3507-x.
   PubMed Web of Science ®Google Scholar
• Reed LJ, Muench H. A simple method of estimating fifty percent endpoints. Am J Hyg. 1938;27:493–7.
   Google Scholar
• Zhou F, Zhou J, Ma L, Song S, Zhang X, Li W, Jiang S, Wang Y, Liao G. High-yield production of a stable Vero cell-based vaccine candidate against the highly pathogenic avian influenza virus H5N1. Biochem Biophys Res Commun. 2012;421(4):850–4. doi:10.1016/j.bbrc.2012.04.101.
   PubMed Web of Science ®Google Scholar
• World Health Organization Global Influenza Surveillance Network. Manual for the laboratory diagnosis and virological surveillance of influenza. Geneva (Switzerland):WHO Press; 2011.
   Google Scholar
• Li C, Shao M, Cui X, Song Y, Li J, Yuan L, Fang H, Liang Z, Cyr TD, Li F, et al. Application of deglycosylation and electrophoresis to the quantification of influenza viral hemagglutinins facilitating the production of 2009 pandemic influenza (H1N1) vaccines at multiple manufacturing sites in China. Biologicals. 2010; 38(2):284–9. doi:10.1016/j.biologicals.2009.12.004.
   PubMed Web of Science ®Google Scholar
• Parker L, Wharton SA, Martin SR, Cross K, Lin Y, Liu Y, Feizi T, Daniels RS, McCauley JW. Effects of egg-adaptation on receptor-binding and antigenic properties of recent influenza A (H3N2) vaccine viruses. J GenVirol. 2016;97(6):1333–44.
   Google Scholar
• Skowronski DM, Janjua NZ, De Serres G, Sabaiduc S, Eshaghi A, Dickinson JA, Fonseca K, Winter AL, Gubbay JB, Krajden M, et al. Low 2012–13 influenza vaccine effectiveness associated with mutation in the egg-adapted h3n2 vaccine strain not antigenic drift in circulating viruses. PLoS ONE. 2014;9(3):e92153. doi:10.1371/journal.pone.0092153.
   PubMed Web of Science ®Google Scholar
• Zost SJ, Parkhouse K, Gumina ME, Kim K, Diaz Perez S, Wilson PC, Treanor JJ, Sant AJ, Cobey S, Hensley SE. Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodieselicited by egg-adapted vaccine strains. Proc Natl Acad Sci. 2017; pii: 201712377.
   Web of Science ®Google Scholar